Amalgamated Bank Kodiak Sciences Inc. Transaction History

Amalgamated Bank

$12.2 Billion
Q4 2024

A detailed history of Amalgamated Bank transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,154 shares of KOD stock, worth $6,658. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,154

Previous 1,154 -0.0%

Holding current value

$6,658

Previous $3,000 266.67%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$3.01 - $7.45 $5,225 - $12,933	-1,736 Reduced 60.07%	1,154 $6,000
Q4 2023 Feb 06, 2024	SELL	$1.4 - $3.24 $480 - $1,111	-343 Reduced 10.61%	2,890 $9,000
Q2 2023 Aug 11, 2023	SELL	$4.3 - $9.48 $911 - $2,009	-212 Reduced 6.15%	3,233 $22,000
Q1 2023 May 02, 2023	SELL	$4.81 - $8.88 $3,713 - $6,855	-772 Reduced 18.31%	3,445 $21,000
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $6,229 - $11,717	-1,236 Reduced 22.67%	4,217 $32,000
Q1 2022 Jun 30, 2022	SELL	$7.09 - $89.45 $3,133 - $39,536	-442 Reduced 7.5%	5,453 $42,000
Q4 2021 Feb 15, 2022	SELL	$80.85 - $128.49 $5,174 - $8,223	-64 Reduced 1.07%	5,895 $500,000
Q3 2021 Oct 29, 2021	SELL	$81.97 - $106.94 $30,001 - $39,140	-366 Reduced 5.79%	5,959 $572,000
Q2 2021 Aug 16, 2021	BUY	$77.2 - $126.54 $126,144 - $206,766	1,634 Added 34.83%	6,325 $588,000
Q1 2021 May 13, 2021	SELL	$110.45 - $164.47 $37,442 - $55,755	-339 Reduced 6.74%	4,691 $532,000
Q4 2020 Feb 12, 2021	BUY	$60.78 - $154.03 $33,246 - $84,254	547 Added 12.2%	5,030 $738,000
Q3 2020 Oct 30, 2020	SELL	$45.05 - $59.27 $6,081 - $8,001	-135 Reduced 2.92%	4,483 $265,000
Q2 2020 Aug 10, 2020	SELL	$42.74 - $66.25 $3,461 - $5,366	-81 Reduced 1.72%	4,618 $250,000
Q1 2020 May 13, 2020	BUY	$38.18 - $73.95 $13,782 - $26,695	361 Added 8.32%	4,699 $224,000
Q4 2019 Feb 13, 2020	BUY	$13.9 - $76.65 $60,298 - $332,507	4,338 New	4,338 $312,000

Others Institutions Holding KOD

# of Institutions

Shares Held

39M

Call Options Held

6.5K

Put Options Held

5.8K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $300M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Kodiak Sciences Inc. Transaction History